UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026324 |
|---|---|
| Receipt number | R000030235 |
| Scientific Title | A phase 2 study of bortezomib, lenalidomide and dexamethasone (VRD) following auto-PBSCT for untreated multiple myeloma. |
| Date of disclosure of the study information | 2017/03/01 |
| Last modified on | 2020/07/28 15:15:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/02/27 21:08:16 | ||
| 2 | Update | 2017/02/28 18:43:57 | UMIN ID1 |
|
| 3 | Update | 2017/09/04 15:55:34 | Public title Public title |
|
| 4 | Update | 2019/11/22 12:56:08 | 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Middle name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 5 | Update | 2019/11/22 12:59:32 | UMIN ID2 |
|
| 6 | Update | 2020/07/28 15:15:41 | Recruitment status Date of IRB Last follow-up date |
